| First Author | Tamargo-Gómez I | Year | 2021 |
| Journal | Cell Death Differ | Volume | 28 |
| Issue | 9 | Pages | 2651-2672 |
| PubMed ID | 33795848 | Mgi Jnum | J:313858 |
| Mgi Id | MGI:6764118 | Doi | 10.1038/s41418-021-00776-1 |
| Citation | Tamargo-Gomez I, et al. (2021) ATG4D is the main ATG8 delipidating enzyme in mammalian cells and protects against cerebellar neurodegeneration. Cell Death Differ 28(9):2651-2672 |
| abstractText | Despite the great advances in autophagy research in the last years, the specific functions of the four mammalian Atg4 proteases (ATG4A-D) remain unclear. In yeast, Atg4 mediates both Atg8 proteolytic activation, and its delipidation. However, it is not clear how these two roles are distributed along the members of the ATG4 family of proteases. We show that these two functions are preferentially carried out by distinct ATG4 proteases, being ATG4D the main delipidating enzyme. In mammalian cells, ATG4D loss results in accumulation of membrane-bound forms of mATG8s, increased cellular autophagosome number and reduced autophagosome average size. In mice, ATG4D loss leads to cerebellar neurodegeneration and impaired motor coordination caused by alterations in trafficking/clustering of GABAA receptors. We also show that human gene variants of ATG4D associated with neurodegeneration are not able to fully restore ATG4D deficiency, highlighting the neuroprotective role of ATG4D in mammals. |
